Literature DB >> 3803145

Predicting relapses of Crohn's disease. Clouds in the crystal ball.

D B Sachar.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3803145     DOI： 10.1007/bf01297109

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  18 in total

1.  Serum lysozyme in inflammatory bowel disease.

Authors:  F W Nugent; R Mallari; H George; N Ridley
Journal:  Gastroenterology       Date:  1976-06       Impact factor: 22.682

2.  IOIBD report no 1: Observer variation in calculating indices of severity and activity in Crohn's disease. International Organisation for the Study of Inflammatory Bowel Disease.

Authors:  F T de Dombal; A Softley
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

3.  An indicator of Crohn's disease activity. A need unfulfilled.

Authors:  B I Korelitz
Journal:  J Clin Gastroenterol       Date:  1986-06       Impact factor: 3.062

4.  Importance of laboratory parameters in the evaluation of Crohn's disease activity.

Authors:  C Brignola; G A Lanfranchi; M Campieri; G Bazzocchi; M Devoto; P Boni; P Farruggia; S Veggetti; A Tragnone
Journal:  J Clin Gastroenterol       Date:  1986-06       Impact factor: 3.062

5.  Crohn's disease activity: assessment by factor VIII coagulation proteins.

Authors:  S Zielen; S W Bender; W Kreuz; H G Posselt; E Solem; I Scharrer
Journal:  J Pediatr Gastroenterol Nutr       Date:  1985-10       Impact factor: 2.839

6.  Crohn's disease activity indexes: need for distinguishing activity from severity.

Authors:  Z Maratka
Journal:  Hepatogastroenterology       Date:  1981-08

7.  Effect of total parenteral nutrition on serum concentrations of eight proteins in Crohn's disease.

Authors:  S Jacobson; A Kallner
Journal:  Am J Gastroenterol       Date:  1984-07       Impact factor: 10.864

8.  Assessment of disease activity in inflammatory bowel disease: a new approach using 111In granulocyte scanning.

Authors:  S H Saverymuttu; J P Lavender; H J Hodgson; V S Chadwick
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-10

9.  Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity.

Authors:  S Meyers; A Wolke; S P Field; E J Feuer; J W Johnson; H D Janowitz
Journal:  Gastroenterology       Date:  1985-07       Impact factor: 22.682

10.  Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease.

Authors:  I Bjarnason; C O'Morain; A J Levi; T J Peters
Journal:  Gastroenterology       Date:  1983-08       Impact factor: 22.682
View more
  4 in total

Review 1.  Recurrence rates in Crohn's disease: predicting the future and predicting the past.

Authors:  D B Sachar
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

2.  Intestinal permeability in gastrointestinal disorders. Use of oral [99mTc]DTPA.

Authors:  R H Resnick; H Royal; W Marshall; R Barron; T Werth
Journal:  Dig Dis Sci       Date:  1990-02       Impact factor: 3.199

3.  Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.

Authors:  T Sahmoud; G Hoctin-Boes; R Modigliani; A Bitoun; J F Colombel; J C Soule; C Florent; J P Gendre; E Lerebours; R Sylvester
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

4.  Health status and health care use in persons with inflammatory bowel disease. A national sample.

Authors:  D A Drossman; J Leserman; C M Mitchell; Z M Li; E A Zagami; D L Patrick
Journal:  Dig Dis Sci       Date:  1991-12       Impact factor: 3.199
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.